60 related articles for article (PubMed ID: 12068634)
1. [Molecular portrait of human kidney carcinomas: the gene expression profiling of protein-tyrosine kinases and tyrosine phosphatases which controlled regulatory signals in the cells].
Cheburkin IuV; Kniazeva TG; Peter S; Kniazev IuP; Karelin MI; Shkol'nik MI; Evtushenko VI; Hanson KP; Ullrich A; Kniazev PG
Mol Biol (Mosk); 2002; 36(3):480-90. PubMed ID: 12068634
[TBL] [Abstract][Full Text] [Related]
2. [Gene expression profiles of protein kinases and phosphatases obtained by hybridization with cDNA arrays: molecular portrait of human prostate carcinoma].
Kniazev IuP; Cheburkin IuV; Spikermann K; Peter S; Jenster G; Bangma KH; Karelin MI; Shkol'nik MI; Urbanskiĭ AI; Evtushenko VI; Ullrich A; Kniazev PG
Mol Biol (Mosk); 2003; 37(1):97-111. PubMed ID: 12624952
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.
Tretiakova M; Turkyilmaz M; Grushko T; Kocherginsky M; Rubin C; Teh B; Yang XJ
J Clin Pathol; 2006 Dec; 59(12):1272-7. PubMed ID: 16556665
[TBL] [Abstract][Full Text] [Related]
4. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinase and phosphatase expression profiling in human cancers.
Lin WC
Methods Mol Biol; 2003; 218():113-25. PubMed ID: 12616716
[TBL] [Abstract][Full Text] [Related]
7. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
Järvinen TA; Tanner M; Bärlund M; Borg A; Isola J
Genes Chromosomes Cancer; 1999 Oct; 26(2):142-50. PubMed ID: 10469452
[TBL] [Abstract][Full Text] [Related]
8. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
Schmidt L; Duh FM; Chen F; Kishida T; Glenn G; Choyke P; Scherer SW; Zhuang Z; Lubensky I; Dean M; Allikmets R; Chidambaram A; Bergerheim UR; Feltis JT; Casadevall C; Zamarron A; Bernues M; Richard S; Lips CJ; Walther MM; Tsui LC; Geil L; Orcutt ML; Stackhouse T; Lipan J; Slife L; Brauch H; Decker J; Niehans G; Hughson MD; Moch H; Storkel S; Lerman MI; Linehan WM; Zbar B
Nat Genet; 1997 May; 16(1):68-73. PubMed ID: 9140397
[TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
Menendez JA; Vellon L; Lupu R
Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
[TBL] [Abstract][Full Text] [Related]
10. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
[TBL] [Abstract][Full Text] [Related]
11. MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array.
Albiges L; Guegan J; Le Formal A; Verkarre V; Rioux-Leclercq N; Sibony M; Bernhard JC; Camparo P; Merabet Z; Molinie V; Allory Y; Orear C; Couvé S; Gad S; Patard JJ; Escudier B
Clin Cancer Res; 2014 Jul; 20(13):3411-21. PubMed ID: 24658158
[TBL] [Abstract][Full Text] [Related]
12. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
Milde-Langosch K; Karn T; Müller V; Witzel I; Rody A; Schmidt M; Wirtz RM
Breast Cancer Res Treat; 2013 Jan; 137(1):57-67. PubMed ID: 23135572
[TBL] [Abstract][Full Text] [Related]
13. TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance.
Wong N; Yeo W; Wong WL; Wong NL; Chan KY; Mo FK; Koh J; Chan SL; Chan AT; Lai PB; Ching AK; Tong JH; Ng HK; Johnson PJ; To KF
Int J Cancer; 2009 Feb; 124(3):644-52. PubMed ID: 19003983
[TBL] [Abstract][Full Text] [Related]
14. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B.
Zhang H; Meng F; Chu CL; Takai T; Lowell CA
Immunity; 2005 Feb; 22(2):235-46. PubMed ID: 15723811
[TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase 1alpha is tyrosine-phosphorylated and inactivated by peroxynitrite in erythrocytes through the src family kinase fgr.
Mallozzi C; De Franceschi L; Brugnara C; Di Stasi AM
Free Radic Biol Med; 2005 Jun; 38(12):1625-36. PubMed ID: 15917191
[TBL] [Abstract][Full Text] [Related]
16. Tumor vessel up-regulation of INSR revealed by single-cell expression analysis of the tyrosine kinome and phosphatome in human cancers.
Kiflemariam S; Ljungström V; Pontén F; Sjöblom T
Am J Pathol; 2015 Jun; 185(6):1600-9. PubMed ID: 25864925
[TBL] [Abstract][Full Text] [Related]
17. A-62176, a potent topoisomerase inhibitor, inhibits the expression of human epidermal growth factor receptor 2.
Kim HL; Jeon KH; Jun KY; Choi Y; Kim DK; Na Y; Kwon Y
Cancer Lett; 2012 Dec; 325(1):72-9. PubMed ID: 22732416
[TBL] [Abstract][Full Text] [Related]
18. Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer.
Chen JR; Chien HP; Chen KS; Hwang CC; Chen HY; Yeh KY; Hsieh TY; Chang LC; Hsu YC; Lu RJ; Hua CC
Medicine (Baltimore); 2017 Jan; 96(2):e5582. PubMed ID: 28079792
[TBL] [Abstract][Full Text] [Related]
19. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B
Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of mesoblastic nephroma and Wilms tumors--comparison and clinical implications.
Sugimura J; Yang XJ; Tretiakova MS; Takahashi M; Kort EJ; Fulton B; Fujioka T; Vogelzang NJ; Teh BT
Urology; 2004 Aug; 64(2):362-8; discussion 368. PubMed ID: 15302496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
